Marcus A Bachhuber1, Christopher B Roberts2, Stephen Metraux3, Ann Elizabeth Montgomery4. 1. Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; Robert Wood Johnson Foundation Clinical Scholars Program, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania. 3. National Center on Homelessness Among Veterans, US Department of Veterans Affairs, Philadelphia, Pennsylvania; Department of Health Policy and Public Health, University of the Sciences, Philadelphia, Pennsylvania. 4. National Center on Homelessness Among Veterans, US Department of Veterans Affairs, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: To determine the prevalence of homelessness and risk for homelessness among veterans with opioid use disorder initiating treatment. SETTING: Addiction treatment programs operated by the US Department of Veterans Affairs (VA). PARTICIPANTS: All veterans initiating treatment with methadone or buprenorphine for opioid use disorder between October 1, 2013 and September 30, 2014 (n = 2,699) who were administered the VA's national homelessness screener. MAIN OUTCOME MEASURES: Self-reported homelessness or imminent risk of homelessness. RESULTS: The prevalence of homelessness was 10.2 percent and 5.3 percent were at risk for homelessness. Compared to male veterans, women veterans were less likely to report homelessness (8.9 percent vs 10.3 percent) but more likely to be at risk (11.8 percent vs 4.9 percent). By age group, veterans aged 18-34 and 45-54 years most frequently reported homelessness (12.0 and 11.7 percent, respectively) and veterans aged 45-54 and 55-64 years most frequently reported risk for homelessness (6.5 and 6.8 percent, respectively). CONCLUSIONS: The prevalence of homelessness in this population is approximately 10 times that of the general veteran population accessing care at VA. Screening identified a substantial number of veterans who could benefit from VA housing assistance and had not received it recently. Programs to address veteran homelessness should engage with veterans seeking addiction treatment. Integration of homelessness services into addiction treatment settings may, in turn, improve outcomes.
OBJECTIVE: To determine the prevalence of homelessness and risk for homelessness among veterans with opioid use disorder initiating treatment. SETTING: Addiction treatment programs operated by the US Department of Veterans Affairs (VA). PARTICIPANTS: All veterans initiating treatment with methadone or buprenorphine for opioid use disorder between October 1, 2013 and September 30, 2014 (n = 2,699) who were administered the VA's national homelessness screener. MAIN OUTCOME MEASURES: Self-reported homelessness or imminent risk of homelessness. RESULTS: The prevalence of homelessness was 10.2 percent and 5.3 percent were at risk for homelessness. Compared to male veterans, women veterans were less likely to report homelessness (8.9 percent vs 10.3 percent) but more likely to be at risk (11.8 percent vs 4.9 percent). By age group, veterans aged 18-34 and 45-54 years most frequently reported homelessness (12.0 and 11.7 percent, respectively) and veterans aged 45-54 and 55-64 years most frequently reported risk for homelessness (6.5 and 6.8 percent, respectively). CONCLUSIONS: The prevalence of homelessness in this population is approximately 10 times that of the general veteran population accessing care at VA. Screening identified a substantial number of veterans who could benefit from VA housing assistance and had not received it recently. Programs to address veteran homelessness should engage with veterans seeking addiction treatment. Integration of homelessness services into addiction treatment settings may, in turn, improve outcomes.
Authors: Nina G Shah; Noya Galai; David D Celentano; David Vlahov; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2005-12-20 Impact factor: 4.492
Authors: Michael Mancino; Geoffrey Curran; Xiaotong Han; Elise Allee; Keith Humphreys; Brenda M Booth Journal: Am J Drug Alcohol Abuse Date: 2010-05 Impact factor: 3.829
Authors: Caleb J Banta-Green; Charles Maynard; Thomas D Koepsell; Elizabeth A Wells; Dennis M Donovan Journal: Addiction Date: 2009-03-13 Impact factor: 6.526
Authors: Daniel P Alford; Colleen T LaBelle; Jessica M Richardson; James J O'Connell; Carole A Hohl; Debbie M Cheng; Jeffrey H Samet Journal: J Gen Intern Med Date: 2007-02 Impact factor: 5.128
Authors: Jayamalathi Priyanka Vakkalanka; Brian C Lund; Stephan Arndt; William Field; Mary Charlton; Marcia M Ward; Ryan M Carnahan Journal: Health Serv Res Date: 2021-12-18 Impact factor: 3.734
Authors: June-Ho Kim; Danielle R Fine; Lily Li; Simeon D Kimmel; Long H Ngo; Joji Suzuki; Christin N Price; Matthew V Ronan; Shoshana J Herzig Journal: PLoS Med Date: 2020-08-07 Impact factor: 11.069
Authors: Priyanka Vakkalanka; Brian C Lund; Stephan Arndt; William Field; Mary Charlton; Marcia M Ward; Ryan M Carnahan Journal: Am J Prev Med Date: 2021-05-19 Impact factor: 5.043